Cargando…
REporting recommendations for tumour MARKer prognostic studies (REMARK)
Despite years of research and hundreds of reports on tumour markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent...
Autores principales: | McShane, L M, Altman, D G, Sauerbrei, W, Taube, S E, Gion, M, Clark, G M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361579/ https://www.ncbi.nlm.nih.gov/pubmed/16106245 http://dx.doi.org/10.1038/sj.bjc.6602678 |
Ejemplares similares
-
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
por: Altman, Douglas G., et al.
Publicado: (2012) -
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
por: Altman, Douglas G, et al.
Publicado: (2012) -
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An
Abridged Explanation and Elaboration
por: Sauerbrei, Willi, et al.
Publicado: (2018) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
por: Mallett, S, et al.
Publicado: (2010) -
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
por: Sekula, Peggy, et al.
Publicado: (2017)